Early Access — free while we kick the tires
EdgarHawk

RECHAN LESLIE J

Director

Director
2 filings analyzed · 1 company · Latest 2025-03-26

Never miss a filing from RECHAN LESLIE J

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
MICROSTRATEGY Inc MSTR 0 2 Net selling

Activity

March 2025
2025-03-26 MICROSTRATEGY Inc MSTR
high
Sell
15,000 shares
$5,038,440
Significance 7/10

MSTR director sells 15,000 shares (75.1% of holdings) for $5,038,440.00 amid unprofitable operations

RECHAN LESLIE J, a director at MicroStrategy, executed 3 separate sales on 2025-03-25 totaling 15,000 shares for $5,038,440.00 at a blended average price of $335.90, reducing his holdings from 19,970 shares to 4,970 shares (a -75.1% reduction). This represents a substantial liquidation of his position at prices $335.31–$337.15, notably above the current price of $329.31. The company's fundamentals are stressed: revenue was $116.1M in the latest quarter with net income of $-340.2M, and annual revenue growth contracted -6.6% year-over-year with full-year losses. Prior to this transaction, his same-ticker trade history at MSTR shows 4 prior sells between November 2024, with 0 of 4 exhibiting well-timed outcomes at the 90-day mark; his cross-ticker track record across all tickers shows a 0.00% 90-day well-timed rate. The scale and composition of this sale—divesting three-quarters of his ownership during a period of revenue decline and substantial losses—merits investor scrutiny of both the underlying business trajectory and the director's confidence assessment.

November 2024
2024-11-12 MICROSTRATEGY Inc MSTR
high
Sell
40,000 shares
$12,015,124
Significance 7/10

Director RECHAN LESLIE J sells 40,000 shares (88.9% of holdings) for $12.0M at MSTR, reducing position to 5.0K shares

RECHAN LESLIE J executed 4 separate sales totaling 40,000 shares for $12,015,124.04 over two trading days (Nov 7–11), reducing his shareholding from 45.0K to 5.0K shares — a 88.9% reduction. The blended average sale price was $300.38, occurring while the stock has since risen to $356.59 (current price), placing the sales in the lower 30% of the 52-week range ($45.02–$356.59). The company reported negative net income of $-340,174,000.00 in the latest quarter against revenue of $116,071,000.00, though the 90-day price performance shows +173.5% gain. This substantial director liquidation of nearly his entire position warrants investor attention to understand the motivation, particularly given the stock's concurrent strength and the company's operating losses.

Related insiders